1. A review of generic preference-based measures for use in cost-effectiveness models;Brazier;Pharmacoeconomics,2017
2. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments;Richardson;Med Decis Making,2015
3. Understanding the composite dimensions of the EQ-5D: an experimental approach;McDonald;Soc Sci Med,2020
4. Manipulating the 5 dimensions of the EuroQol instrument: the effects on self-reporting actual health and valuing hypothetical health states [published correction appears in Med Decis Making. 2020;40(2):115];Tsuchiya;Med Decis Making,2019
5. Bryan S., Jowett S., Hardyman W., Bentham P. Does the EQ-5D anxiety/depression item measure anxiety, depression, both or neither? 21st Plenary Meeting of the EuroQol Group. Chicago, US; 16-18 September 2004.